- Pfizer (New York, NY)
- …trial(s) in support of the development strategy for programs within the Late -Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for ... similar role in industry/CRO + Clinical Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and with a track record of… more
- Pfizer (New York, NY)
- …+ Medical degree with 5+ years of industry experience + Clinical oncology experience (typically 4+ years) **Preferred Qualifications** Board certified/eligible in ... oncology or equivalent preferred Breast Oncology experience (2+ years) **Organizational Relationships** Reports to Global Development Lead and partners closely… more
- Bristol Myers Squibb (Princeton, NJ)
- …Read more: careers.bms.com/working-with-us . **Position Title: VP, GPL Franchise Lead Oncology ** **Position Summary** + Accountable for maximizing the value of the ... Oncology portfolio by shaping the end-to-end disease strategy, in...applicable + Expertise in the drug development process, especially late development space, relevant regulatory expectations, and overall drug… more
- Bristol Myers Squibb (Princeton, NJ)
- …a robust enterprise level strategy for asset(s) and indication(s) including early, late and post-marketing development, as well as awareness of the enterprise ... through proof of concept trials and will to assure a seamless transition into late stage development (Phase II-III trials) + Ability to lead and develop a group… more
- Bristol Myers Squibb (Princeton, NJ)
- …They will be foundational in working with teams in Research, Early and Late Development, providing insights into biology, translational elements, as well as overall ... indications (lupus, scleroderma, myositis, rheumatoid arthritis) * Work closely with hematology/ oncology physicians to coordinate CAR-T cell therapy treatment in the… more
- Taiho Oncology (Princeton, NJ)
- Looking for a chance to make a meaningful difference in the oncology space? Taiho Oncology is on a mission: to improve the lives of patients with cancer, their ... the global regulatory CMC activities except Asia for all assigned Taiho Oncology Inc., (TOI) projects; provides strategic regulatory guidance especially for CMC… more
- Sumitomo Pharma (New York, NY)
- …Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology, and cell & ... and Europe, and a diverse pipeline of early- to late -stage assets, we aim to accelerate discovery, research, and...Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene… more
- Ascendis Pharma (Princeton, NJ)
- …United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology . Here at Ascendis, we pride ourselves on exceptional science, visionary ... improve the quality of Adverse Event intake. + Performs late case investigation and risk mitigation strategy. Ability to...case investigation and risk mitigation strategy. Ability to review late case(s) to determine Root Cause Analysis (RCA) and… more
- Bristol Myers Squibb (Princeton, NJ)
- …proof of concept trials and will assure a seamless transition into late stage development (Phase II-III trials.) **Governance Participation and Signature Authority** ... since this position has responsibility for strategy and clinical research in oncology in multiple geographies + Experience interacting with business development and… more
- Bristol Myers Squibb (New Brunswick, NJ)
- …and post-marketing safety for the breadth of the BMS portfolio in oncology , hematology, cardiovascular disease, fibrosis, immunology and neurology. Located in any of ... + Act as a Nonclinical Safety representative on early- and late -stage project development teams. + Provides scientifically and strategically sound nonclinical… more
- Ascendis Pharma (Princeton, NJ)
- …United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology . Here at Ascendis, we pride ourselves on exceptional science, visionary ... Regulatory framework and understanding of the overall drug development process, early and late stage (IND, CTA, BLA, NDA, MAA). + Experience in participating in… more